OUCRU Hanoi Staff Photos (2022)

Professor H. Rogier van Doorn

Director of OUCRU Ha Noi

Rogier is a Clinical Microbiologist from the Netherlands who has worked at OUCRU Ho Chi Minh City from 2007 – 2015 and now leads the OUCRU Ha Noi unit, hosted by the National Hospital of Tropical Diseases.

Expertise

As head of the virology lab for the Southeast Asian Infectious Disease Clinical Research Network, he has led analysis of several diagnostic and intervention studies on human influenza, developed diagnostic lab capacity in local hospitals and a BSL3/SAPO4 facility at OUCRU. He has worked on diagnostics, preparedness and clinical research of emerging infections, and set up and led a multidisciplinary research programme on Hand, Foot, and Mouth Disease.

In Ha Noi, based at the National Hospital for Tropical Diseases, Rogier leads a research programme that covers various aspects of research on bacterial drug resistant infections; including laboratory diagnostics, microbiome research, community interventions, and antibiotic stewardship; and public and policy engagement.

Research Focus

His research interests are improving surveillance for antimicrobial resistance through A Clinically Oriented Antimicrobial resistance surveillance Network (ACORN), serology-based surveillance of emerging and vaccine-preventable diseases, and studying AMR, influenza, and other respiratory infections in a community household cohort in Ha Nam province.

Timeline

2015

Became Director of OUCRU Ha Noi.

2003 – 2007

MD – Academic Medical Center, Amsterdam (NL), Faculty of Medicine.

1999-2005

PhD – University of Amsterdam (NL), Faculty of Medicine, Amsterdam University Medical Centers – Academic Medical Center, Department of Medical Microbiology. Isoniazid resistance in Mycobacterium tuberculosis.

1990 – 1998

MD – Consultant Clinical Microbiology and Virology, Amsterdam University Medical Centers. Registrations: RIBIZ (NL) 69052473801, GMC (UK) 6168758.

1994 – 1996

MSc – Medical Biology, University of Amsterdam (NL), Faculty of Biology.

Publications

Loading...
Suntornsut P, Asadinia KS, Limato R, Tamara A, Rotty L W A, Bramanti R, Nusantara D U, Nelwan E J, Khusuwan S, Suphamongkholchaikul W, Chamnan P, Piyaphanee W, Lan Vu H T, Nguyen Y H, Nguyen K H, Pham T N, Le Q M, Hai Vu V, Chau D M, Hoang Vo D E T, Harriss E K, van Doorn H R, Hamers R L, Lorencatto F, Atkins L, Limmathurotsakul D
BMJ Open
February 19, 2024
DOI: 10.1136/bmjopen-2023-075526
Nguyen Van Vinh Chau, Tang Chi Thuong, Nguyen Thanh Hung, Nguyen Thi Thu Hong, Du Tuan Quy, Tran Ba Thien, Cao Minh Hiep, Ngo Ngoc Quang Minh, Truong Huu Khanh, Do Duong Kim Han, Truong Hoang Chau Truc, Nguyen Thi Han Ny, Le Kim Thanh, Lam Anh Nguyet, Cao Thu Thuy, Le Nguyen Truc Nhu, Pham Van Quang, Phung Nguyen The Nguyen, Phan Tu Qui, H Rogier van Doorn, C Louise Thwaites, Tran Tan Thanh, Nguyen Thanh Dung, Guy Thwaites, Nguyen To Anh, Le Nguyen Thanh Nhan, Le Van Tan; SEACOVARIANTS1
Emerg Infect Dis
February 1, 2024
DOI: 10.3201/eid3002.231024
Just Transitions for AMR Working Group (Sheila Rose Varadan, Clare Isobel Rosina Chandler, Kym Weed, Syed Masud Ahmed, Caesar Atuire, Deepshikha Batheja, Susan Jane Bull, Sander Chan, Hindrik Rogier van Doorn, Ashish Giri, Ren Gerrets, Steve Hinchliffe, Calvin Ho, Pablo Imbach, Marina Joubert, Claas Kirchhelle, Taciano L Milfont, Sassy Molyneux, Edna Nduku Mutua, Christopher Pell, Nenene Qekwana, Yin Mo, Phaik Yeong Cheah, Sonia Lewycka)
Lancet
September 8, 2023
DOI: 10.1016/S0140-6736(23)01687-2
1 2 49
Skip to content